Oruka’s long-acting psoriasis therapy posts strong results in mid-stage study Drug could become new treatment option, and a blockbuster, if data hold up in late-stage trials

https://www.statnews.com/2026/04/27/ourka-psoriasis-inectable-treatment-study/ By Adam FeuersteinApril 27, 2026 Adam Feuerstein, a senior writer and biotech columnist, is the author of Adam’s Biotech Scorecard, a subscriber-only newsletter about the crossroads of drug development, business, Wall Street, and biotechnology.